Skip to Content

Torii Pharmaceutical Co Ltd TRXPF

Morningstar Rating
$24.57 −0.93 (3.65%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TRXPF is trading at a 77% premium.
Price
$24.56
Fair Value
$91.86
Uncertainty
High
1-Star Price
$72.67
5-Star Price
$86.41
Economic Moat
Lypl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TRXPF is a good fit for your portfolio.

Trading Information

Previous Close Price
$25.50
Day Range
$24.5724.57
52-Week Range
$24.5725.50
Bid/Ask
$0.01 / $912.85
Market Cap
$690.25 Mil
Volume/Avg
140 / 130

Key Statistics

Price/Earnings (Normalized)
22.10
Price/Sales
1.61
Dividend Yield (Trailing)
1.68%
Dividend Yield (Forward)
1.68%
Total Yield
1.68%

Company Profile

Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
626

Comparables

Valuation

Metric
TRXPF
INVA
1SKF401E
Price/Earnings (Normalized)
22.109.95
Price/Book Value
0.681.44
Price/Sales
1.614.43
Price/Cash Flow
13.808.24
Price/Earnings
TRXPF
INVA
1SKF401E

Financial Strength

Metric
TRXPF
INVA
1SKF401E
Quick Ratio
5.208.515.90
Current Ratio
6.5010.425.90
Interest Coverage
9.81
Quick Ratio
TRXPF
INVA
1SKF401E

Profitability

Metric
TRXPF
INVA
1SKF401E
Return on Assets (Normalized)
5.21%14.79%11.93%
Return on Equity (Normalized)
5.79%29.29%14.50%
Return on Invested Capital (Normalized)
5.54%16.71%14.48%
Return on Assets
TRXPF
INVA
1SKF401E
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRCvcdtrgkPxmpth$78.2 Bil
ZTS
Zoetis Inc Class AZlhllhtksBhhqv$78.0 Bil
HLN
Haleon PLC ADRLbcpfmhJbkdm$37.4 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRZcjrxqjnYksrl$19.1 Bil
VTRS
Viatris IncVnpnqjmlJjdv$12.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRGlkmllbcGxnv$11.8 Bil
CTLT
Catalent IncMdgzrqgqTqwgcd$9.9 Bil
PRGO
Perrigo Co PLCNsbsjnjtXttv$3.8 Bil
CURLF
Curaleaf Holdings IncFmbjbswwGrzr$3.5 Bil
PBH
Prestige Consumer Healthcare IncSffkqzmklGhysff$3.2 Bil

Sponsor Center